slider one Manipulation
of Biologicals
Preclinical Research, Manufacturing, and Diagnostics. overlay // Scalable Platform for the LEARN MORE
// From Research to Manufacturing triangle LEARN MORE bar Recombinant
Protein Purification
slide 3 overlay // Autologous and Allogeneic Cell Therapies Cell Therapy
slider 4 // From Research to Manufacturing overlay bar triangle LEARN MORE Recombinant
Antibody Purification

Advanced Therapy Medicinal Products

Proteios is developing an innovative approach that empowers an organization’s discovery and manufacturing of Advanced Therapy Medicinal Products (ATMPs). Some of the anticipated advantages of ATMPs include: highly personalized therapy, direct application through infusion, longer lasting effect, address complex diseases, and improving health-related quality of life. Complex manufacturing and compliance with GMP standards has been a major challenge for the progress of ATMPs. The Proteios Chimera Platform is enabling: 1) new discoveries in Preclinical Research to better understand disease at the molecular level, 2) the cost-effective manufacturing of Biopharmaceuticals, Cell Therapies, Gene Therapies, and Antibody Therapeutics, 3) and the development of novel molecular diagnostics. 

Interested in Proteios news and updates?